Cargando…

The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies

Neuromelanin granules (NMGs) are organelle-like structures present in the human substantia nigra pars compacta. In addition to neuromelanin, NMGs contain proteins, lipids and metals. As NMG-containing dopaminergic neurons are preferentially lost in Parkinson’s disease and dementia with Lewy bodies (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wulf, Maximilian, Barkovits, Katalin, Schork, Karin, Eisenacher, Martin, Riederer, Peter, Gerlach, Manfred, Eggers, Britta, Marcus, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688080/ https://www.ncbi.nlm.nih.gov/pubmed/36428966 http://dx.doi.org/10.3390/cells11223538

Ejemplares similares

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
por: Wulf, Maximilian, et al.
Publicado: (2022)

Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection
por: Plum, Sarah, et al.
Publicado: (2016)

Advanced Fiber Type-Specific Protein Profiles Derived from Adult Murine Skeletal Muscle
por: Eggers, Britta, et al.
Publicado: (2021)

Quality Control—A Stepchild in Quantitative Proteomics: A Case Study for the Human CSF Proteome
por: Rozanova, Svitlana, et al.
Publicado: (2023)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

CSF Diagnostics: A Potentially Valuable Tool in Neurodegenerative and Inflammatory Disorders Involving Motor Neurons: A Review
por: Krause, Karsten, et al.
Publicado: (2021)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Neuromelanin is an immune stimulator for dendritic cells in vitro
por: Oberländer, Uwe, et al.
Publicado: (2011)

Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research
por: Schilde, Lukas M., et al.
Publicado: (2018)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
por: Plum, Sarah, et al.
Publicado: (2020)

Reproducibility, Specificity and Accuracy of Relative Quantification Using Spectral Library-based Data-independent Acquisition
por: Barkovits, Katalin, et al.
Publicado: (2020)

Dataset containing physiological amounts of spike-in proteins into murine C2C12 background as a ground truth quantitative LC-MS/MS reference
por: Uszkoreit, Julian, et al.
Publicado: (2022)

A proteomic signature for dementia with Lewy bodies
por: O'Bryant, Sid E., et al.
Publicado: (2019)

[(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
por: Mak, Elijah, et al.
Publicado: (2021)

Let me infuse this for you – A way to solve the first YPIC challenge
por: Eggers, Britta, et al.
Publicado: (2019)

Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies
por: Lachén-Montes, Mercedes, et al.
Publicado: (2020)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19
por: Wolny, Monika, et al.
Publicado: (2023)

Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients
por: Gámez-Valero, Ana, et al.
Publicado: (2019)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Glucocorticoid receptor complexes form cooperatively with the Hsp90 co-chaperones Pp5 and FKBPs
por: Kaziales, Anna, et al.
Publicado: (2020)

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
por: Choi, Sunah, et al.
Publicado: (2023)

Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson’s Disease and Its Inherent Risk for Melanoma
por: Leupold, Dieter, et al.
Publicado: (2019)

BIONDA: a free database for a fast information on published biomarkers
por: Turewicz, Michael, et al.
Publicado: (2021)

Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin
por: Nakamura, Ken, et al.
Publicado: (2014)

Dysfunctional brain dynamics and their origin in Lewy body dementia
por: Schumacher, Julia, et al.
Publicado: (2019)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Spatial Perseveration in Dementia with Lewy Bodies
por: Assal, Frédéric, et al.
Publicado: (2007)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b1brimj5c46ug869e0ig3honb6